dsdsa

product

2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

We constantly continually give you essentially the most conscientious client provider, plus the widest variety of designs and styles with finest materials. These initiatives include the availability of customized designs with speed and dispatch for China Melatonine Powder, Calcium Folinate, Rocuronium, We have been one of your largest 100% manufacturers in China. A lot of large trading businesses import products and solutions from us, so we can easily give you the most beneficial price tag with the same quality for anyone who is interested in us.
2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai Detail:

Product name Cabazitaxel
Synonyms (αR,βS)-β-[[(1,1-DiMethylethoxy)carbonyl]aMino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-diMethoxy-4a,8,13,13-tetraMethyl-5-oxo-7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester
CAS No. 183133-96-2
Appearance White to almost white crystalline solid
Molecular Formula C45H57NO14
Molecular Weight 835.93
Application Pharma grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Cabazitaxel CAS:183133-96-2

ITEMS STANDARDS RESULTS
CHARACTERISTICS White to almost white crystalline solid White crystalline solid
IDENTIFICATION Should to positive Positive
SOUBILITY Freely soluble in Acetone and Dichloromethane,Soluble in Ethanol and Methanol, Sparingly soluble in Ethyl acetate. Complies
LOSS ON DRYING ≤1.0% 0.1%
RESIDUE ON IGNITION ≤0.2% 0.05%
HEAVY METALS ≤20ppm Complies
RELATIVE SUBSTANCE Single impurity:≤0.3% 0.08%
Total Impurities:≤0.8 % 0.19%
RESIDUAL SOLVENT Tetrahydrofuran:≤0.072%Methanol: ≤0.3%

Dichloromethane:≤0.06%

Ethyl Acetate: ≤0.5%

Not DetectedNot Detected

Not Detected

Not Detected

ASSAY NLT 98.5% 99.78%
Conclusion:It complies to prescribed enterprise standard

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures

2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures

2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures


Related Product Guide:

We insist over the principle of development of 'High top quality, Performance, Sincerity and Down-to-earth working approach' to supply you with exceptional services of processing for 2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai , The product will supply to all over the world, such as: Pakistan, Brunei, Puerto Rico, The best and original quality for spare parts is a most important factor for transportation. We may stick on supplying original and good quality parts even a little profit earned. God will bless us to do kindness business forever.
  • This manufacturer can keep improving and perfecting products and service, it is in line with the rules of market competition, a competitive company.
    5 Stars By Anne from Islamabad - 2017.09.28 18:29
    Adhering to the business principle of mutual benefits, we have a happy and successful transaction, we think we will be the best business partner.
    5 Stars By Dee Lopez from Qatar - 2017.05.21 12:31
    Write your message here and send it to us